David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
CALL
MongoDB
MDB
$32.6B
| $8.72M | 0.01% |
59,300
+17,200
| +41% | +$1.77M |
|
|
GTS
1152
DELISTED
Triple-S Management Corporation
GTS
| $8.71M | 0.01% |
401,223
+86,545
| +28% | +$1.76M |
|
1153
Comfort Systems
FIX
$55B
| $8.69M | 0.01% |
165,843
+13,522
| +9% | +$675K |
|
1154
PUT
PVH
PVH
$3.44B
| $8.68M | 0.01% |
71,200
+19,100
| +37% | +$2.09M |
|
1155
CALL
Check Point Software Technologies
CHKP
$13.2B
| $8.66M | 0.01% |
68,500
+29,800
| +77% | +$3.46M |
|
1156
Murphy USA
MUSA
$10B
| $8.64M | 0.01% |
100,862
+1,286
| +1% | +$102K |
|
1157
PUT
Corpay
CPAY
$27.1B
| $8.63M | 0.01% |
35,000
| – | – |
|
1158
Zurn Elkay Water Solutions
ZWS
$8.1B
| $8.61M | 0.01% |
710,638
-33,104
| -4% | -$412K |
|
|
CORE
1159
DELISTED
Core Mark Holding Co., Inc.
CORE
| $8.6M | 0.01% |
231,615
+96,539
| +71% | +$3.04M |
|
|
IVC
1160
DELISTED
Invacare Corporation
IVC
| $8.57M | 0.01% |
1,023,642
+456,746
| +81% | +$3.29M |
|
1161
PUT
Intuitive Surgical
ISRG
$131B
| $8.56M | 0.01% |
45,000
-277,500
| -86% | -$49.3M |
|
1162
CNO Financial Group
CNO
$5.01B
| $8.55M | 0.01% |
528,612
-42,380
| -7% | -$718K |
|
1163
Greif
GEF
$4.81B
| $8.55M | 0.01% |
207,305
+193,300
| +1,380% | +$7.72M |
|
|
FBC
1164
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $8.54M | 0.01% |
259,507
+47,021
| +22% | +$1.47M |
|
1165
PUT
Stellantis
STLA
$19.8B
| $8.54M | 0.01% |
575,000
+361,700
| +170% | +$5.56M |
|
1166
CALL
Nike
NKE
$58.6B
| $8.52M | 0.01% |
101,200
-44,400
| -30% | -$3.66M |
|
1167
CALL
Deere & Co
DE
$170B
| $8.5M | 0.01% |
53,200
-144,400
| -73% | -$23.1M |
|
1168
Herc Holdings
HRI
$5.22B
| $8.5M | 0.01% |
218,148
-26,216
| -11% | -$991K |
|
1169
AB InBev
BUD
$155B
| $8.49M | 0.01% |
101,159
-7,509
| -7% | -$577K |
|
|
AFI
1170
DELISTED
Armstrong Flooring, Inc.
AFI
| $8.49M | 0.01% |
624,294
-4,901
| -0.8% | -$66.9K |
|
1171
PUT
Phillips 66
PSX
$94.5B
| $8.49M | 0.01% |
89,200
+26,400
| +42% | +$2.51M |
|
|
LPT
1172
DELISTED
Liberty Property Trust
LPT
| $8.47M | 0.01% |
174,953
-154,656
| -47% | -$7.2M |
|
1173
Fortive
FTV
$18B
| $8.44M | 0.01% |
159,577
-63,802
| -29% | -$3.11M |
|
1174
Thomson Reuters
TRI
$45.2B
| $8.44M | 0.01% |
135,303
+8,291
| +7% | +$463K |
|
|
SCHW
1175
Charles Schwab
SCHW
$194B
| $8.42M | 0.01% |
+196,885
| New | +$8.89M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.